David Ortega-Alarcón

833 total citations
19 papers, 479 citations indexed

About

David Ortega-Alarcón is a scholar working on Molecular Biology, Computational Theory and Mathematics and Genetics. According to data from OpenAlex, David Ortega-Alarcón has authored 19 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Computational Theory and Mathematics and 6 papers in Genetics. Recurrent topics in David Ortega-Alarcón's work include Computational Drug Discovery Methods (8 papers), Genetics and Neurodevelopmental Disorders (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). David Ortega-Alarcón is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Genetics and Neurodevelopmental Disorders (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). David Ortega-Alarcón collaborates with scholars based in Spain, Italy and Peru. David Ortega-Alarcón's co-authors include Adrián Velázquez‐Campoy, Olga Abián, Sonia Vega, Ana Jiménez-Alesanco, Laura Ceballos-Laita, Bruno Rizzuti, Hugh T. Reyburn, Frederico Ferreira‐da‐Silva, Margarida Bastos and C. Mark Johnson and has published in prestigious journals such as Nucleic Acids Research, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

David Ortega-Alarcón

18 papers receiving 469 citations

Peers

Countries citing papers authored by David Ortega-Alarcón

Since Specialization

Citations

This map shows the geographic impact of David Ortega-Alarcón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ortega-Alarcón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ortega-Alarcón more than expected).

Fields of papers citing papers by David Ortega-Alarcón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ortega-Alarcón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ortega-Alarcón. The network helps show where David Ortega-Alarcón may publish in the future.

Co-authorship network of co-authors of David Ortega-Alarcón

This figure shows the co-authorship network connecting the top 25 collaborators of David Ortega-Alarcón. A scholar is included among the top collaborators of David Ortega-Alarcón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ortega-Alarcón. David Ortega-Alarcón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Inhibition of SARS-CoV-2 3CLpro by chemically modified tyrosinase from Agaricus bisporus 2024 ·RSC Medicinal Chemistry ·(unknown), David Ortega-Alarcón, Ángela Vázquez-Calvo, Veronica Ricci, Olga Abián, Adrián Velázquez‐Campoy, Antonio Alcamı́, José M. Palomo	0
2	Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), David Ortega-Alarcón, Ana Jiménez-Alesanco, Sonia Vega, Olga Abián, Adrián Velázquez‐Campoy, Timothy M. Thomson, Marta Pinto, José M. Granadino‐Roldán, María Santos Tomás Belenguer, Juan J. Pérez, J. Rubio	1
3	Extending MeCP2 interactome: canonical nucleosomal histones interact with MeCP2 2024 ·Nucleic Acids Research ·David Ortega-Alarcón, Rafael Claveria‐Gimeno, Sonia Vega, (unknown), (unknown), Manel Esteller, Juan Ausió, Olga Abián, Adrián Velázquez‐Campoy	8
4	Nanostructured biohybrid material with wide-ranging antiviral action 2023 ·Nano Research ·Noelia Losada‐Garcia, Ángela Vázquez-Calvo, David Ortega-Alarcón, Olga Abián, Adrián Velázquez‐Campoy, Pilar Domingo‐Calap, Antonio Alcamı́, José M. Palomo	4
5	Unexpected thermodynamic signature for the interaction of hydroxymethylated DNA with MeCP2 2023 ·International Journal of Biological Macromolecules ·David Ortega-Alarcón, Rafael Claveria‐Gimeno, Sonia Vega, (unknown), Manel Esteller, Olga Abián, Adrián Velázquez‐Campoy	4
6	Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 Mpro Main Protease Inhibitors 2023 ·Pharmaceuticals ·(unknown), (unknown), David Ortega-Alarcón, Ana Jiménez-Alesanco, Sonia Vega, Olga Abián, Adrián Velázquez‐Campoy, Timothy M. Thomson, José M. Granadino‐Roldán, (unknown), J. Rubio	5
7	Isothermal titration calorimetry 2023 ·Nature Reviews Methods Primers ·Margarida Bastos, Olga Abián, C. Mark Johnson, Frederico Ferreira‐da‐Silva, Sonia Vega, Ana Jiménez-Alesanco, David Ortega-Alarcón, Adrián Velázquez‐Campoy	83
8	MEP pathway products allosterically promote monomerization of deoxy-D-xylulose-5-phosphate synthase to feedback-regulate their supply 2022 ·Plant Communications ·(unknown), David Ortega-Alarcón, Ramu Kakumanu, Javier Iglesias‐Fernández, (unknown), Edward E. K. Baidoo, Adrián Velázquez‐Campoy, Manuel Rodríguez‐Concepción, Jordi Pérez-Gil	23
9	Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation 2022 ·Journal of Medicinal Chemistry ·Francisca Pinheiro, Irantzu Pallarès, Francesca Peccati, (unknown), Nathalia Varejão, (unknown), David Ortega-Alarcón, Danilo González, (unknown), Susanna Navarro, Adrián Velázquez‐Campoy, Maria Rosário Almeida, David Reverter, Félix Busquè, Ramón Alibés, Mariona Sodupe, Salvador Ventura	10
10	Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs 2021 ·Biomedicines ·Bruno Rizzuti, Fedora Grande, Filomena Conforti, Ana Jiménez-Alesanco, Laura Ceballos-Laita, David Ortega-Alarcón, Sonia Vega, Hugh T. Reyburn, Olga Abián, Adrián Velázquez‐Campoy	64
11	Residual Helicity at the Active Site of the Histidine Phosphocarrier, HPr, Modulates Binding Affinity to Its Natural Partners 2021 ·International Journal of Molecular Sciences ·José L. Neira, David Ortega-Alarcón, Bruno Rizzuti, Martina Palomino‐Schätzlein, Adrián Velázquez‐Campoy, Alberto Falcó	2
12	Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds 2021 ·Pharmaceuticals ·Bruno Rizzuti, Laura Ceballos-Laita, David Ortega-Alarcón, Ana Jiménez-Alesanco, Sonia Vega, Fedora Grande, Filomena Conforti, Olga Abián, Adrián Velázquez‐Campoy	21
13	The armadillo-repeat domain of plakophilin 1 binds the C-terminal sterile alpha motif (SAM) of p73 2021 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·José L. Neira, Bruno Rizzuti, David Ortega-Alarcón, Ana Marcela Giudici, Olga Abián, María Esther Fárez‐Vidal, Adrián Velázquez‐Campoy	5
14	Influence of the disordered domain structure of MeCP2 on its structural stability and dsDNA interaction 2021 ·International Journal of Biological Macromolecules ·David Ortega-Alarcón, Rafael Claveria‐Gimeno, Sonia Vega, (unknown), Manel Esteller, Olga Abián, Adrián Velázquez‐Campoy	10
15	l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells 2021 ·Molecules ·Luca Sancineto, Carmine Ostacolo, David Ortega-Alarcón, Ana Jiménez-Alesanco, Laura Ceballos-Laita, Sonia Vega, Olga Abián, Adrián Velázquez‐Campoy, Silvia Moretti, Agnieszka Dąbrowska, Paweł Botwina, (unknown), Anna Kula, Krzysztof Pyrć, Nunzio Iraci, Claudio Santi	7
16	Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 M^pro Protease through Virtual Screening 2021 ·Journal of Chemical Information and Modeling ·J. Rubio, Ana Jiménez-Alesanco, Laura Ceballos-Laita, David Ortega-Alarcón, Sonia Vega, (unknown), (unknown), Olga Abián, Adrián Velázquez‐Campoy, Timothy M. Thomson, José M. Granadino‐Roldán, (unknown), Juan J. Pérez	20
17	Stabilization Effect of Intrinsically Disordered Regions on Multidomain Proteins: The Case of the Methyl-CpG Protein 2, MeCP2 2021 ·Biomolecules ·David Ortega-Alarcón, Rafael Claveria‐Gimeno, Sonia Vega, (unknown), Manel Esteller, Olga Abián, Adrián Velázquez‐Campoy	11
18	Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening 2020 ·International Journal of Biological Macromolecules ·Olga Abián, David Ortega-Alarcón, Ana Jiménez-Alesanco, Laura Ceballos-Laita, Sonia Vega, Hugh T. Reyburn, Bruno Rizzuti, Adrián Velázquez‐Campoy	192
19	Molecular Context-Dependent Effects Induced by Rett Syndrome-Associated Mutations in MeCP2 2020 ·Biomolecules ·David Ortega-Alarcón, Rafael Claveria‐Gimeno, Sonia Vega, (unknown), Manel Esteller, Olga Abián, Adrián Velázquez‐Campoy	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact